Hemangiosarcoma in Dogs: Early Detection, Treatment...

Hemangiosarcoma is one of the most aggressive & heartbreaking cancers that can affect dogs. Arising from the cells lining blood vessels, this malignant tumor can develop silently in virtually any organ — most commonly the spleen, heart, & liver — before revealing itself through sudden, often catastrophic symptoms. For dog owners, understanding hemangiosarcoma is essential because early detection can make a meaningful difference in treatment options & quality of life.

In this comprehensive guide, we explore everything you need to know about hemangiosarcoma in dogs: what causes it, how to recognize the warning signs, what treatment options exist, & what prognosis you can expect. Whether you have just received a diagnosis or want to be prepared, this article will help you navigate this challenging disease with knowledge & compassion.

Disclaimer: This article is for informational purposes only & does not constitute veterinary advice. Always consult a licensed veterinarian for diagnosis & treatment decisions regarding your dog's health.

What Is Hemangiosarcoma in Dogs?

Hemangiosarcoma (sometimes abbreviated as HSA) is a malignant cancer that originates from endothelial cells — the thin layer of cells that line the interior surface of blood vessels & lymphatic vessels. Because blood vessels exist throughout the entire body, hemangiosarcoma can theoretically develop anywhere. However, it most frequently appears in specific locations:

• Spleen: The most common site, accounting for roughly 45–50% of all hemangiosarcoma cases in dogs. Splenic hemangiosarcoma often grows as a large mass that can rupture, causing life-threatening internal bleeding.
• Heart (right atrium): Approximately 25% of cases involve the heart, where tumors can interfere with normal cardiac function & lead to fluid buildup around the heart (pericardial effusion).
• Liver: Hepatic hemangiosarcoma accounts for a smaller but significant percentage of cases & behaves similarly to the splenic form.
• Skin (dermal): Cutaneous hemangiosarcoma appears on the skin surface & is sometimes linked to sun exposure, particularly in light-colored or thinly coated breeds.
• Other organs: Less commonly, hemangiosarcoma can affect the lungs, kidneys, bones, muscles, bladder, or other tissues.

One of the defining characteristics of hemangiosarcoma is its high metastatic rate. Even when the primary tumor appears localized, microscopic cancer cells have often already spread to other organs by the time of diagnosis. This is what makes the disease so challenging to treat & why early detection is so critically important.

According to veterinary oncology research, hemangiosarcoma accounts for approximately 5–7% of all canine tumors. It predominantly affects middle-aged to older dogs, with the average age of onset between 8 & 13 years. Certain breeds appear to be predisposed, including German Shepherds, Golden Retrievers, Labrador Retrievers, Boxers, & English Setters. Male dogs may be slightly more affected than females in some studies.

If you are concerned about cancer risks in your dog, exploring our health & wellbeing resources can help you stay informed about other conditions that may affect your furry companion.

Causes & Risk Factors for Canine Hemangiosarcoma

The exact cause of hemangiosarcoma in dogs remains incompletely understood. Like many cancers, it likely results from a complex interplay of genetic predisposition, environmental factors, & age-related cellular changes. However, several risk factors have been identified through veterinary research:

Genetic Predisposition

Certain breeds are significantly overrepresented in hemangiosarcoma cases, strongly suggesting a hereditary component. German Shepherds are among the most commonly affected breeds, with some studies indicating they may be up to five times more likely to develop the disease compared to mixed-breed dogs. Golden Retrievers & Labrador Retrievers also show elevated risk, which may relate to broader genetic susceptibility to various cancers within these breeds.

Ongoing genomic research is working to identify specific gene mutations associated with hemangiosarcoma susceptibility. Understanding these genetic markers could eventually lead to screening tests that help breeders & owners identify at-risk dogs earlier in life.

Age

Hemangiosarcoma is predominantly a disease of middle-aged & senior dogs. While it can occur in younger animals, the vast majority of cases are diagnosed in dogs between 8 & 13 years of age. As dogs age, accumulated cellular damage & declining immune surveillance may create conditions more favorable for cancer development.

Environmental Factors

For dermal (skin) hemangiosarcoma, ultraviolet radiation from sun exposure is a recognized contributing factor, particularly in dogs with light-colored fur, thin coats, or sparsely haired areas like the belly & inner thighs. Breeds such as Whippets, American Staffordshire Terriers, & white Boxers may be more vulnerable to sun-induced skin hemangiosarcoma.

Some studies have explored potential links between environmental toxins, chemical exposures, & hemangiosarcoma risk, though conclusive evidence remains limited. Maintaining a healthy environment for your dog, minimizing exposure to known carcinogens, & providing a balanced lifestyle are sensible general precautions.

Spay/Neuter Status

Some research has suggested that early spaying or neutering may influence cancer risk in certain breeds, including hemangiosarcoma. However, the data is complex & sometimes contradictory. The decision to spay or neuter — & the timing of that procedure — should always be discussed with your veterinarian in the context of your individual dog's breed, size, & overall health profile.

Recognizing the Symptoms: Early Detection of Hemangiosarcoma

One of the most insidious aspects of hemangiosarcoma is that it often progresses silently until the disease is advanced. Dogs are remarkably stoic animals, & tumors growing internally may not cause noticeable symptoms until they reach a critical size or rupture. This makes vigilance & awareness absolutely essential for dog owners.

General Warning Signs

The following symptoms may indicate hemangiosarcoma or other serious health conditions & should always prompt a veterinary visit:

• Lethargy & weakness: Unexplained tiredness, reluctance to exercise, or a noticeable decrease in energy levels.
• Pale gums: Gums that appear white, grayish, or very pale pink instead of healthy bubblegum pink can indicate internal bleeding or anemia.
• Abdominal swelling: A distended or bloated abdomen may signal internal bleeding from a ruptured splenic or hepatic tumor, or fluid accumulation.
• Weight loss & decreased appetite: Unexplained weight loss or a sudden disinterest in food can be associated with many cancers.
• Difficulty breathing: Labored breathing, rapid breathing, or coughing may occur with cardiac hemangiosarcoma or metastatic lung involvement.
• Collapsing episodes: Sudden collapse or fainting spells — especially if the dog seems to recover afterward — are a hallmark sign of splenic hemangiosarcoma that has begun to bleed intermittently.
• Lumps or masses on the skin: Dermal hemangiosarcoma may appear as raised, dark red or black, bruise-like lesions on the skin that may ulcerate or bleed.

The Significance of Collapsing Episodes

Episodic collapse is one of the most characteristic — & most alarming — presentations of splenic hemangiosarcoma. What typically happens is that the tumor bleeds internally, causing a sudden drop in blood pressure & oxygen delivery to the brain. The dog collapses, appears weak or unresponsive, but then the body manages to temporarily stop the bleeding, & the dog recovers — sometimes within minutes to hours.

These episodes are sometimes mistaken for seizures, heart problems, or simple aging. However, any unexplained collapse warrants immediate veterinary evaluation. Each episode represents significant internal blood loss, & a future rupture could be catastrophic & non-recoverable.

Early Detection Strategies

Given the silent nature of hemangiosarcoma, proactive screening is one of the best tools available for early detection, particularly in predisposed breeds:

• Regular veterinary wellness exams: Semi-annual checkups for senior dogs allow your veterinarian to palpate the abdomen, listen to the heart, & identify subtle changes over time.
• Routine blood work: Complete blood counts (CBC) can reveal anemia or abnormal red blood cell fragments (schistocytes) that may hint at hemangiosarcoma. Biochemistry panels & clotting tests can provide additional clues.
• Abdominal ultrasound: For high-risk breeds, some veterinarians recommend periodic abdominal ultrasounds starting around age 7 or 8 to screen for splenic or hepatic masses before symptoms develop.
• Cardiac screening: Echocardiography (ultrasound of the heart) can detect right atrial masses, though this is typically performed when cardiac symptoms are present or as part of a broader screening protocol.
• Know your dog's normal: Familiarity with your dog's typical energy level, appetite, gum color, & behavior allows you to notice subtle deviations that might otherwise go unremarked.

For more guidance on keeping your dog healthy as they age, check out our senior dog care resources & learn how proactive health monitoring can improve outcomes.

Treatment Options for Hemangiosarcoma in Dogs

Treatment for hemangiosarcoma depends on several factors, including the tumor's location, whether metastasis has occurred, the dog's overall health, & the owner's goals for treatment. A board-certified veterinary oncologist is typically involved in developing the most appropriate treatment plan.

Surgery

Surgical removal of the primary tumor is often the first line of treatment when feasible:

• Splenectomy: For splenic hemangiosarcoma, removing the spleen (splenectomy) is the most common surgical intervention. This can be a life-saving emergency procedure if the tumor has ruptured & caused severe internal bleeding. Even in non-emergency situations, removing the spleen eliminates the primary tumor burden & can provide immediate relief from symptoms.
• Cardiac surgery: Right atrial hemangiosarcoma is more surgically challenging. In some cases, a pericardial window (creating an opening in the sac surrounding the heart) may be performed to relieve fluid buildup, though complete tumor removal from the heart is rarely possible.
• Dermal excision: Skin hemangiosarcoma may be treated with wide surgical excision, often with curative intent if the tumor has not spread. Dermal hemangiosarcoma generally carries a better prognosis than internal forms.
• Liver resection: In select cases where a hepatic hemangiosarcoma is confined to a single liver lobe, surgical removal of that lobe may be attempted.

It is important to understand that surgery alone is rarely curative for internal hemangiosarcoma because microscopic metastasis has usually already occurred by the time of diagnosis. Surgery is most effective when combined with adjuvant therapies.

Chemotherapy

Chemotherapy is the standard adjuvant treatment following surgery for hemangiosarcoma. The most commonly used protocol involves doxorubicin (Adriamycin), typically administered intravenously every two to three weeks for a series of four to six treatments. Doxorubicin-based chemotherapy has been shown to extend survival times compared to surgery alone.

Other chemotherapy agents that may be used alone or in combination include:

• Vincristine
• Cyclophosphamide
• Dacarbazine
• Liposomal doxorubicin (a formulation designed to reduce cardiac toxicity)

Side effects of chemotherapy in dogs are generally milder than in humans. Most dogs maintain a good quality of life during treatment, though monitoring for gastrointestinal upset, decreased appetite, & bone marrow suppression is important.

Targeted Therapy & Emerging Treatments

Veterinary oncology is an evolving field, & several newer approaches are being explored for hemangiosarcoma:

• Metronomic chemotherapy: This involves administering low doses of oral chemotherapy drugs (such as cyclophosphamide) on a daily basis. The goal is to inhibit blood vessel formation (anti-angiogenesis) that tumors need to grow, rather than directly killing cancer cells.
• Tyrosine kinase inhibitors: Drugs like toceranib phosphate (Palladia) target specific molecular pathways involved in tumor growth & blood vessel formation. These may be used in combination with traditional chemotherapy or as maintenance therapy.
• Immunotherapy: Researchers are investigating immune-based approaches, including vaccines designed to stimulate the dog's own immune system to recognize & attack hemangiosarcoma cells.
• Ebulloside & other novel compounds: Various experimental drugs & compounds are under investigation in clinical trials, offering hope for improved outcomes in the future.

Participation in clinical trials may be an option for some dogs & can provide access to cutting-edge treatments while contributing to scientific knowledge. Your veterinary oncologist can advise you on available trials.

Palliative & Supportive Care

For dogs with advanced disease, metastatic spread, or when owners opt against aggressive treatment, palliative care focuses on maintaining comfort & quality of life:

• Pain management: Appropriate analgesics ensure the dog remains comfortable.
• Fluid therapy: Intravenous fluids may be administered during acute bleeding episodes to support blood pressure & hydration.
• Blood transfusions: In cases of severe anemia from internal bleeding, a transfusion can be life-saving & provide temporary stabilization.
• Nutritional support: A highly palatable, nutrient-dense diet helps maintain body condition & energy.
• Anti-nausea medications & appetite stimulants: These help ensure the dog continues eating during treatment or in advanced disease stages.

Prognosis & Life Expectancy

The prognosis for hemangiosarcoma varies considerably depending on the tumor location, stage at diagnosis, & treatment approach. It is important to have realistic expectations while also recognizing that individual outcomes can differ significantly from statistical averages.

Splenic Hemangiosarcoma

Without treatment, dogs with splenic hemangiosarcoma typically survive only one to three months after diagnosis. With splenectomy alone (surgery without chemotherapy), median survival times range from approximately one to three months. When splenectomy is combined with doxorubicin-based chemotherapy, median survival times extend to roughly four to six months, with some dogs living a year or longer.

A small percentage of dogs — approximately 10% — survive beyond one year with aggressive combination treatment. Factors associated with longer survival include smaller tumor size at diagnosis, absence of visible metastasis, & the dog's overall health status.

Cardiac Hemangiosarcoma

Heart-based hemangiosarcoma generally carries a more guarded prognosis than the splenic form. Median survival with supportive care alone is typically one to two months. Surgical intervention (pericardial window) combined with chemotherapy may extend survival to approximately four to six months in some cases.

Dermal (Skin) Hemangiosarcoma

Cutaneous hemangiosarcoma has a notably better prognosis than internal forms, particularly when the tumor is confined to the superficial skin layers & can be completely excised surgically. Median survival times for dermal hemangiosarcoma can exceed one year, & some dogs are effectively cured with complete surgical removal. However, subcutaneous (deeper skin layer) hemangiosarcoma behaves more aggressively, with prognosis closer to that of internal forms.

Factors Affecting Prognosis

Several variables influence individual outcomes:

• Stage of disease: Dogs diagnosed before tumor rupture or metastasis tend to have better outcomes.
• Tumor location: Dermal tumors have the best prognosis; cardiac tumors the worst.
• Treatment approach: Combination therapy (surgery + chemotherapy) consistently outperforms single-modality treatment.
• Overall health: Dogs without concurrent serious health conditions tolerate treatment better & may live longer.
• Metastatic status: The presence or absence of detectable metastasis at diagnosis significantly impacts survival expectations.

While the statistics can be sobering, it is essential to remember that quality of life matters as much as quantity. Many dogs with hemangiosarcoma enjoy weeks or months of happy, comfortable life with appropriate treatment & care. Working closely with your veterinary team to monitor your dog's wellbeing & make compassionate decisions is the most important thing you can do.

When to See a Veterinarian

Because hemangiosarcoma can progress rapidly & cause sudden, life-threatening emergencies, knowing when to seek veterinary attention is critical. Contact your veterinarian or an emergency veterinary hospital immediately if your dog exhibits any of the following:

• Sudden collapse, fainting, or inability to stand
• Extremely pale or white gums
• Rapid, unexplained abdominal distension
• Severe difficulty breathing or labored respiration
• Uncontrolled bleeding from a skin mass
• Repeated vomiting, especially with blood
• Sudden, profound weakness or unresponsiveness

These signs may indicate a hemangiosarcoma rupture or other serious emergency that requires immediate intervention. Minutes can matter in these situations, so do not delay seeking care.

For non-emergency concerns, schedule a veterinary appointment promptly if you notice:

• Unexplained weight loss or decreased appetite lasting more than a few days
• Gradual lethargy or exercise intolerance that persists
• New lumps, bumps, or skin lesions, especially dark-colored or bruise-like masses
• Intermittent episodes of weakness that seem to resolve on their own
• Chronic coughing or changes in breathing patterns

For high-risk breeds — particularly German Shepherds, Golden Retrievers, & Labrador Retrievers — discuss proactive screening protocols with your veterinarian starting around age seven. Regular abdominal ultrasounds & blood work can potentially detect hemangiosarcoma at an earlier, more treatable stage.

Learn more about recognizing common dog health issues & when professional veterinary evaluation is needed to keep your companion safe.

Frequently Asked Questions

Is hemangiosarcoma painful for dogs?

Hemangiosarcoma can cause discomfort & pain, particularly when tumors grow large enough to press on surrounding organs, when they rupture & cause internal bleeding, or when metastasis affects bones or other sensitive tissues. However, many dogs with early-stage hemangiosarcoma do not appear to be in obvious pain, which is partly why the disease is so difficult to detect early. Your veterinarian can assess your dog's pain level & prescribe appropriate pain management medications to ensure comfort throughout treatment or palliative care.

Can hemangiosarcoma in dogs be prevented?

Unfortunately, there is currently no proven method to prevent hemangiosarcoma in dogs. Because the disease has a strong genetic component, especially in predisposed breeds, complete prevention is not yet possible. However, you can take steps to reduce risk & improve early detection: maintain regular veterinary wellness exams, discuss breed-specific screening protocols with your vet, limit excessive sun exposure for light-colored & thin-coated dogs (to reduce dermal hemangiosarcoma risk), provide a balanced diet & healthy lifestyle, & stay vigilant for any changes in your dog's behavior, energy level, or physical appearance. Research into genetic screening & preventive strategies is ongoing.

How is hemangiosarcoma diagnosed in dogs?

Diagnosing hemangiosarcoma typically involves a combination of approaches. Your veterinarian may start with a physical examination, blood work (including a complete blood count & biochemistry panel), & imaging studies such as abdominal ultrasound, chest X-rays, or echocardiography. Ultrasound can reveal masses in the spleen, liver, or heart, while chest X-rays help identify metastatic spread to the lungs. A definitive diagnosis requires histopathology — microscopic examination of tissue obtained through biopsy or after surgical removal of the mass. In emergency situations where a tumor has ruptured, surgery may be performed first to stabilize the dog, with the removed tissue sent for pathological analysis afterward.

What is the difference between hemangioma & hemangiosarcoma in dogs?

Both hemangiomas & hemangiosarcomas arise from blood vessel lining cells, but they differ fundamentally in behavior. A hemangioma is a benign (non-cancerous) tumor that does not metastasize or invade surrounding tissues aggressively. Hemangiomas are often found incidentally on the spleen or skin & may require no treatment if they are not causing problems. Hemangiosarcoma, by contrast, is a malignant (cancerous) tumor that is locally invasive, has a high rate of metastasis, & is life-threatening. Distinguishing between the two requires pathological examination of the tissue, which is why any splenic mass or suspicious skin lesion should be evaluated by a veterinarian & biopsied when appropriate. It is worth noting that not all splenic masses are cancerous — studies suggest that roughly 40–50% of splenic masses in dogs may be benign, which is why diagnostic testing is so important before making treatment decisions.

How can I support my dog's quality of life after a hemangiosarcoma diagnosis?

Supporting your dog after a hemangiosarcoma diagnosis involves a combination of medical care, comfort measures, & emotional attention. Work closely with your veterinary team to develop a treatment or palliative care plan tailored to your dog's needs. Ensure your dog has a comfortable, quiet resting area with easy access to water & food. Follow prescribed medication schedules carefully, including pain management, anti-nausea drugs, or chemotherapy protocols. Monitor your dog daily for changes in appetite, energy, gum color, & breathing. Keep a journal of symptoms & behaviors to share with your veterinarian at follow-up appointments. Most importantly, spend quality time together — gentle walks, favorite activities, & affectionate companionship contribute enormously to your dog's emotional wellbeing during this challenging time. If your dog's quality of life declines significantly despite treatment, have an open & honest conversation with your veterinarian about humane end-of-life options.

Final Thoughts

Hemangiosarcoma is undoubtedly one of the most challenging diagnoses a dog owner can face. Its aggressive nature, tendency toward silent progression, & high metastatic rate make it a formidable adversary. However, knowledge is empowering. By understanding the risk factors, recognizing early warning signs, pursuing appropriate screening for at-risk breeds, & working with a skilled veterinary team, you can make the most informed decisions possible for your beloved companion.

Whether your dog is undergoing active treatment, receiving palliative care, or you are simply preparing yourself with knowledge for the future, remember that the love & care you provide every day matters profoundly. Every moment of comfort, every gentle walk, every shared quiet afternoon is meaningful — for both of you.

For more information on dog health, nutrition, & wellbeing, explore the resources available at Paws & Tales & continue learning how to give your furry friend the best possible life.